Relmada Therapeutics
RLMD
RLMD
72 hedge funds and large institutions have $393M invested in Relmada Therapeutics in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 14 closing their positions.
Holders
72
Holders Change
-3
Holders Change %
-4%
% of All Funds
1.46%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
11
Increased
22
Reduced
19
Closed
14
Calls
$5.79M
Puts
$11K
Net Calls
+$5.78M
Net Calls Change
-$4.86M
Top Buyers
| 1 |
ACA
1
Avoro Capital Advisors
New York
|
$56.4M |
| 2 |
2
Aviva
London,
United Kingdom
|
$2.29M |
| 3 |
3
SG Americas Securities
New York
|
$2.33M |
| 4 |
4
Bank of New York Mellon
New York
|
$6.68M |
| 5 |
ACP
5
Acuta Capital Partners
Redwood City,
California
|
$10.4M |
